Method of decreasing fasting sugars and weight gains in diabetic patients
OwnerWilliam H. Landschulzinventor
Life of this patent
Estimating the term…
Abstract
Inhaled insulin, relative to subcutaneously and/or transdermally administered insulin, can be used to prevent the rate of weight gain and to lower the levels of fasting glucose in diabetic patients.
Claims14
A method of reducing the rate of weight gain in a diabetic patient who is using exogenous insulin to control blood sugars and who is taking said insulin by the subcutaneous and/or transdermal route of administration, comprising administering said insulin to said patient by the pulmonary route.
A method of lowering the fasting glucose level in a diabetic patient who is using exogenous insulin to control blood sugars and who is taking said insulin by the subcutaneous and/or transdermal route of administration, comprising administering said insulin to said patient by the pulmonary route.
Dependencies are inferred from the claim text.